Susquehanna International Group
ETTX

Susquehanna International Group’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History

Susquehanna International Group’s Portfolio ETTX Stock Details ETTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-393,563
Closed -$866K – 14866
2022
Q2 		$866K Buy
393,563
+376,187
+2,165% +$751K ﹤0.01% 6889
2022
Q1 		$32K Sell
17,376
-47,970
-73% -$87.3K ﹤0.01% 12489
2021
Q4 		$143K Buy
+65,346
New +$177K ﹤0.01% 11850

Susquehanna International Group's ETTX Position: Q3 2022 in Review

Susquehanna International Group sold out of Entasis Therapeutics Holdings Inc. (ETTX) in Q3 2022, closing a stake of 393,563 shares — an estimated $866K sold.

Susquehanna International Group first reported a position in ETTX in Q4 2021 and held it in 3 quarters. The position peaked at $866K in Q2 2022. 0 funds tracked by Wall St. Rank hold ETTX as of Q3 2022.

  • Susquehanna International Group reported no remaining Entasis Therapeutics Holdings Inc. position as of Q3 2022 after selling out during the quarter.
  • Susquehanna International Group sold 393,563 Entasis Therapeutics Holdings Inc. shares in Q3 2022, an estimated $866K.
  • Susquehanna International Group first reported a position in Entasis Therapeutics Holdings Inc. in Q4 2021 and held it in 3 quarters.
  • Susquehanna International Group's Entasis Therapeutics Holdings Inc. position peaked at $866K in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Entasis Therapeutics Holdings Inc. as of Q3 2022.

Based on Susquehanna International Group's 13F filing for Q3 2022, filed 14 Nov 2022.